Biomarker measurements: how far have we come and where are we heading?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biomarker measurements: how far have we come and where are we heading?

Published:2016-12 Issue:23 Volume:8 Page:2383-2386
ISSN:1757-6180
Container-title:Bioanalysis
language:en
Short-container-title:Bioanalysis

Author:

Amaravadi Lakshmi¹

Affiliation:

1. Translational Medicine & Early Development, Sanofi-Genzyme, Framingham, MA, USA

Publisher

Future Science Ltd

Subject

Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry

Link

http://www.future-science.com/doi/pdf/10.4155/bio-2016-4987

Reference17 articles.

1. Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspective

2. Building a roadmap to biomarker qualification: challenges and opportunities

3. Implications of the Institute of Medicine Report: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

4. Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement

5. Method validation and application of protein biomarkers: basic similarities and differences from biotherapeutics

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The breadth of biomarkers and their assays: part 2;Bioanalysis;2016-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3